Publications

Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

AuthID
P-00N-MHP

Author(s)

Asselah, T

Kowdley, KV

Zadeikis, N

Wang, S

Hassanein, T

Horsmans, Y

Colombo, M

Calinas, F

Aguilar, H

de Ledinghen, V

[+2]·

Marinho, RT

Agarwal, K

Nevens, F

Elkhashab, M

Kort, J

Liu, R

Ng, TI

Krishnan, P

Lin, CW

Mensa, FJ

View all authors

Document Type

Article

Year published

2018

Published

in CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, ISSN: 1542-3565

Volume: 16, Issue: 3, Pages: 417-426 (10)

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.cgh.2017.09.027

Wos: WOS:000425097800028

Source Identifiers

ISSN: 1542-3565

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Name	Name Order	Name	Name Order	Name
1	Asselah, T;	2	Kowdley, KV;	3	Zadeikis, N;
4	Wang, S;	5	Hassanein, T;	6	Horsmans, Y;
7	Colombo, M;	8	Calinas, F;	9	Aguilar, H;
10	de Ledinghen, V;	11	Mantry, PS;	12	Hezode, C;
13	Marinho, RT;	14	Agarwal, K;	15	Nevens, F;
16	Elkhashab, M;	17	Kort, J;	18	Liu, R;
19	Ng, TI;	20	Krishnan, P;	21	Lin, CW;
22	Mensa, FJ;

Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

Useful Links

Get Help

Federated Authentication (Click on the image)

Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

Useful Links

Get Help